S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
Silicon Motion Proves That AI in Motion Stays in Motion
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
Silicon Motion Proves That AI in Motion Stays in Motion
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
Silicon Motion Proves That AI in Motion Stays in Motion
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
ASML’s Earnings Could Bring The Stock to New Highs
Kinder Morgan Stock Bid Up In An Oil Breakout
Undervalued UnitedHealth Group Won’t Be For Long
Silicon Motion Proves That AI in Motion Stays in Motion
DocuSign and The Case for 66% Upside 
3 Computer Vision Stocks for Long-Term Gains From AI
Closing prices for crude oil, gold and other commodities

Oncimmune (ONC) News Today

GBX 25.20
0.00 (0.00%)
(As of 04/16/2024 09:20 PM ET)
SourceHeadline
wsj.com logoOncimmune Holdings PLC
wsj.com - March 19 at 4:44 PM
finance.yahoo.com logoOncimmune Holdings Full Year 2023 Earnings: UK£0.085 loss per share (vs UK£0.13 loss in FY 2022)
finance.yahoo.com - March 2 at 4:43 AM
reuters.com logoCancer test firm Freenome raises $254 mln in fresh funding
reuters.com - February 15 at 7:56 AM
msn.com logoActivist investor Kelso gains board seats at The Works as it tries to enhance shareholder value
msn.com - February 14 at 10:49 AM
proactiveinvestors.com.au logoOncimmune seeing commercial traction as it inks new deals with big pharma companies
proactiveinvestors.com.au - December 2 at 8:51 AM
yahoo.com logoThe Unique Use of Liquid Biopsy
yahoo.com - September 26 at 9:29 AM
marketwatch.com logoOncimmune's Acting CEO Ron Kirschner Steps Down, Takes COO Role; Gouldstone Starts as CEO
marketwatch.com - August 1 at 7:22 PM
marketwatch.com logoOncimmune Shares Fall As Company Lowers FY 2022 Revenue Result
marketwatch.com - July 14 at 12:36 PM
lse.co.uk logoOncimmune names chief executive successor, while finance chief leaves
lse.co.uk - July 12 at 8:31 AM
marketwatch.com logoOncimmune Holdings Appoints Martin Gouldstone CEO; CFO Matthew Hall to Step Down
marketwatch.com - July 12 at 8:31 AM
lse.co.uk logoOncimmune Holdings shakes up leadership and unveils new growth plan
lse.co.uk - June 23 at 8:29 AM
marketwatch.com logoOncimmune CEO Adam Hill to Step Down; Sees Tough End to FY 2023
marketwatch.com - June 23 at 8:29 AM
lse.co.uk logoOncimmune shares plummet as interim revenue falls by fifth
lse.co.uk - May 31 at 10:08 AM
marketwatch.com logoOncimmune Shares Fall on 1H Pretax Loss
marketwatch.com - May 31 at 10:08 AM
lse.co.uk logoOncimmune sells two subsidiaries to Freenome for GBP13 million
lse.co.uk - May 22 at 9:56 AM
markets.businessinsider.com logoFREENOME ACQUIRES GLOBAL IMMUNODIAGNOSTICS DEVELOPER ONCIMMUNE LTD
markets.businessinsider.com - May 22 at 9:56 AM
marketwatch.com logoOncimmune Eases Going-Concern Risk With Sale of Two Subsidiaries for GBP13 Mln
marketwatch.com - May 22 at 9:56 AM
marketwatch.com logoThe Comprehensive Guide to the Cancer Biopsy Market: Trends and Revenue Forecast with predicted CAGR of 4.2% from 2023-2030
marketwatch.com - April 28 at 12:56 PM
marketwatch.com logoCancer Biopsy Market Outlook by 2031
marketwatch.com - April 22 at 8:06 AM
finance.yahoo.com logoOncolytics Biotech® to Participate in a Panel Presentation at Canaccord Genuity's Horizons in Oncology Virtual Conference
finance.yahoo.com - April 12 at 7:46 AM
proactiveinvestors.com logoOncimmune delivering top-line growth
proactiveinvestors.com - February 28 at 5:13 AM
marketwatch.com logoOncimmune Shares Fall After Going Concern Warning, Pretax Loss
marketwatch.com - February 27 at 7:10 AM
lse.co.uk logoCORRECT: Oncimmune works with Siemens Healthineers on cancer therapy
lse.co.uk - February 20 at 8:45 AM
theguardian.com logoRichard Sharp: BBC chair was shareholder in firm awarded £600k while he was a No 10 adviser
theguardian.com - January 25 at 7:39 PM
finance.yahoo.com logoInvestors in Oncimmune Holdings (LON:ONC) have unfortunately lost 67% over the last year
finance.yahoo.com - January 2 at 12:28 PM
marketwatch.com logoOncimmune Holdings to Raise at Least GBP2.1 Mln; Mulls EarlyCDT IPO
marketwatch.com - December 7 at 3:53 PM
finance.yahoo.com logoInstitutional investors own a significant stake of 48% in Oncimmune Holdings plc (LON:ONC)
finance.yahoo.com - October 13 at 12:27 PM
lse.co.uk logoOncimmune shares plummet as company reports widened pretax loss
lse.co.uk - September 21 at 10:43 AM
marketwatch.com logoOncimmune FY 2022 Pretax Loss Widens on Higher Costs; Shares Fall
marketwatch.com - September 21 at 5:41 AM
uk.finance.yahoo.com logoOncimmune Holdings Plc (ONC.L)
uk.finance.yahoo.com - September 2 at 6:56 PM
finance.yahoo.com logoEstimating The Fair Value Of Oncimmune Holdings plc (LON:ONC)
finance.yahoo.com - July 31 at 9:54 AM
finance.yahoo.com logoFurther weakness as Oncimmune Holdings (LON:ONC) drops 12% this week, taking one-year losses to 56%
finance.yahoo.com - June 16 at 3:32 AM
benzinga.com logoGlobal Cancer Biopsy Market to Reach USD 43,692 Million | Growing at CAGR of 10.7% | Insights and Tools and Forecast 2028
benzinga.com - June 2 at 8:19 PM
proactiveinvestors.com.au logoOncimmune receives 2022 Queen's Award for Enterprise
proactiveinvestors.com.au - April 21 at 8:47 AM
proactiveinvestors.com.au logoFTSE 100 ends the week higher as Wall Street also recovers
proactiveinvestors.com.au - April 8 at 3:15 PM
proactiveinvestors.com logoFTSE follows US rally while Elon Musk faces potential SEC probe and UK starting salaries rise
proactiveinvestors.com - April 8 at 3:15 PM
lse.co.uk logoOncimmune agrees two new commercial contracts
lse.co.uk - April 8 at 3:15 PM
proactiveinvestors.com.au logoOncimmune lands follow-on Covid study contract
proactiveinvestors.com.au - March 7 at 7:21 AM
marketwatch.com logoOncimmune Holdings Wins Follow-On Contract for Covid-19 Study
marketwatch.com - March 7 at 7:21 AM
marketwatch.com logoOncimmune 1H Pretax Loss Widened as Covid-19 Restrictions Ease
marketwatch.com - February 28 at 9:39 AM
morningstar.com logoOncimmune Signs Contract With Verily Life Sciences to Investigate Long-Covid
morningstar.com - February 28 at 4:38 AM
marketwatch.com logoOncimmune Holdings's Lung Blood Test to Be Used in Spanish Region
marketwatch.com - February 17 at 7:04 AM
proactiveinvestors.com logoOncimmune lung cancer diagnostic receives regulatory green light from second Spanish regional health authority
proactiveinvestors.com - February 17 at 7:04 AM
markets.businessinsider.com logoOncimmune Hldgs PLC : Results from COVID-19 autoantibody profiling panel
markets.businessinsider.com - January 4 at 10:29 AM
lse.co.uk logoOncimmune study suggests antibodies spike following Covid infection
lse.co.uk - December 31 at 9:47 AM
markets.businessinsider.com logoOncimmune Hldngs PLC : Grant of Options and PDMR Dealing
markets.businessinsider.com - December 26 at 11:57 PM
markets.businessinsider.com logoOncimmune Hldngs PLC : ImmunoINSIGHTS commercial update
markets.businessinsider.com - December 22 at 9:51 AM
markets.businessinsider.com logoOncimmune Hldngs PLC : PDMR Dealing
markets.businessinsider.com - December 22 at 9:51 AM
lse.co.uk logoOncimmune shares up after multiple commercial contract wins
lse.co.uk - December 21 at 1:17 PM
marketwatch.com logoOncimmune Signs Deal With Major Pharma Company to Provide Autoantibody Biomarker Services
marketwatch.com - December 21 at 8:17 AM
Get Oncimmune News Delivered to You Automatically

Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter.

Can't believe it's happening again (Ad)

One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.

We explain how this event works in full right here.

ONC Media Mentions By Week

ONC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ONC
News Sentiment

0.00

0.58

Average
Medical
News Sentiment

ONC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ONC Articles
This Week

0

0

ONC Articles
Average Week

Get Oncimmune News Delivered to You Automatically

Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (LON:ONC) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners